Evidence map›Paper›PMID 34693102›Full record

ArticleCurrent opinion in biomedical engineering2021

Integrating in vitro disease models of the neurovascular unit into discovery and development of neurotherapeutics.

Yunfeng Ding, Eric V Shusta, Sean P Palecek

Abstract read
In one paragraph

Article in Current opinion in biomedical engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Dynamic Pathophysiological Insight into the Brain by NIR-II Imaging.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yunfeng DingDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI, USA.
Eric V ShustaDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI, USA.
Sean P PalecekDepartment of Chemical and Biological Engineering, University of Wisconsin-Madison, Madison, WI, USA.

Funding

Exploring Blood-Brain Barrier Dysfunction in Alzheimer's DiseaseR01NS109486 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI SHUSTA, ERIC V · 2018 to 2022
$1.9M
Cilia as a biomarker of CNS vascular healthR33HL154254 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI NAULI, SURYA, PALECEK, SEAN P · 2022 to 2024
$1.9M
Mechanisms of Shear Induction of Blood-Brain Barrier Phenotypes in Human iPSC-derived Brain Endothelial ProgenitorsR01NS107461 · NINDS · UNIVERSITY OF WISCONSIN-MADISON · PI PALECEK, SEAN P · 2019 to 2023
$1.7M
Cilia as a biomarker of CNS vascular healthR61HL154254 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI NAULI, SURYA, PALECEK, SEAN P · 2020 to 2021
$1.3M
NHLBI NIH HHS R33 HL154254NHLBI NIH HHS R61 HL154254NINDS NIH HHS R01 NS107461NINDS NIH HHS R01 NS109486
6 · The paper itself

Abstract

The blood-brain barrier (BBB) regulates the transport of small molecules, proteins, and cells between the bloodstream and the central nervous system (CNS). Brain microvascular endothelial cells work with other resident brain cell types, including pericytes, astrocytes, neurons, and microglia, to form the neurovascular unit (NVU) and maintain BBB integrity. The restrictive barrier influences the pathogenesis of many CNS diseases, and impedes the delivery of neurotherapeutics into the CNS.

Indexed as

Blood-brain barrierDisease ModellingDrug DeliveryNeurotherapeuticNeurovascular unit

Identifiers

PMID34693102
PMCPMC8530278

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.